Nutrition, Exercise, and Integrative Approach for Osteoporosis - and - Transgender Bone Health in 2024
A 25-minute talk that will discuss the role of nutrition (particularly calcium and vitamin D) and weight-bearing exercise in the treatment of osteoporosis. Then, a 25-minute session that will discuss the impact of gender affirming therapies on bone health in transgender and gender diverse people.
OBJECTIVES
Nutrition, Exercise, and Integrative Approach for Osteoporosis:
- Understand the role of calcium and vitamin-D on bone density and fracture risk.
- Understand the value of other minerals and vitamins in skeletal health.
- Understand the impact of exercise in the treatment of osteoporosis.
Transgender Bone Health in 2024:
- To discuss the impact of gender affirming hormone therapy on bone density.
- To list common causes of low bone density among transgender and gender diverse people.
- To update guidelines on the bone health in transgender and gender diverse people.
Daniel L. Hurley, MD, FACE
Associate Professor of Medicine
Mayo Clinic College of Medicine and Science
Dr. Daniel L. Hurley graduated from the University of South Dakota Medical School in 1980 and completed both his Internal Medicine Residency and Endocrinology Fellowship at the Mayo Graduate School of Medicine. He was awarded the Randall G. Sprague Award for Outstanding Achievement as an Endocrine Fellow. In 1986, Dr. Hurley joined the Mayo Staff and is a Consultant in the Division of Endocrinology, Diabetes, Metabolism and Nutrition. In recognition by his peers, he was awarded the Henry S. Plummer Distinguished Physician Award from the Mayo Department of Medicine in 2005.
Dr. Hurley is Associate Professor of Medicine at Mayo Clinic College of Medicine and Science. He was Director of the Endocrine Fellowship Program from 1992 to 1997. Dr. Hurley has been annually recognized for his excellence in teaching and received the Teacher of the Year Award from the Mayo Graduate School Residents and Fellows in 1992. Dr. Hurley has served as site co-director for Effective Communication-in-Healthcare (CIH) faculty in Rochester an executive member of the Mayo Program on Professionalism and Values at Mayo Clinic.
Dr. Hurley’s primary clinical interests are osteoporosis and metabolic bone diseases, outpatient nutrition/obesity and bariatric surgery, and hospital nutrition. He has served as a past member of the American Society for Parenteral and Enteral Nutrition (ASPEN), and as a member and chair of the American Society of Bone and Mineral (ASBMR) Adult Bone and Mineral Working Group. Dr. Hurley was appointed to the United States President’s Council on Fitness, Sports, and Nutrition Science Board from 2014 to 2016.
Dr. Hurley is a charter member (1992) of the American Association of Clinical Endocrinologists (AACE), is a Fellow of the American College of Endocrinology (FACE) and has served as President of the MN-Midwest Chapter of AACE and on the national AACE Board of Directors from 2007 to 2020, to include being elected President of AACE from 2018-2019 and serving as AACE Chancellor from 2019 to 2020.
Vin Tangpricha, MD, PhD
Professor of Medicine, Eminent Physician
Division of Endocrinology, Metabolism & Lipids, Emory University School of Medicine
Vin Tangpricha is a Professor of Medicine in the Division of Endocrinology, Metabolism and Lipids at Emory University School of Medicine in Atlanta, Georgia. Dr. Tangpricha received his medical degree from Tufts University School of Medicine and completed his internal medicine residency and endocrinology fellowship at Boston University Medical Center. He completed his PhD in molecular medicine on the topic of vitamin D at Boston University School of Medicine. He serves on the Endocrine Society guidelines committee for the hormone treatment of gender-non-conforming and gender incongruent patients, which has published two international guidelines on transgender patients (2009 and revised in 2017). He served on the World Professional Association for Transgender Health (WPATH) guidelines for the Standards of Care (SOC) for Transgender people as the endocrine section chair. He is the immediate past-president of WPATH. He has received funding from the Cystic Fibrosis Foundation and NIH. He has published over 250 peer reviewed manuscripts on transgender medicine, vitamin D, and cystic fibrosis.